An unusual case of gemcitabine-induced radiation recall

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 29, Issue 6, 2006, Pages 636-

  Squire, Sarah ^a   Chan, Michael ^b   Feller, Edward ^a   Mega, Anthony ^a   Gold, Richard ^a  

^a BROWN UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gemcitabine; Myositis; Radiation recall

Indexed keywords

GEMCITABINE; PREDNISONE;

ADULT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CONFERENCE PAPER; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; HUMAN; LUNG ADENOCARCINOMA; MYALGIA; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; RADIATION INJURY; RADIATION RECALL; SKIN DISEASE; TREATMENT PLANNING; TREATMENT RESPONSE;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; FEMALE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; MYOSITIS; PALLIATIVE CARE; RADIODERMATITIS;

EID: 33845498122     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000182426.43595.25     Document Type: Conference Paper

References (4)

1. Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol. 2001;59:237-245.
2. Jeter MD, Jänne PA, Brooks S, et al. Gemcitabine-induced radiation recall. Int J Radiation Oncology Biol Phys. 2002;53:394-400.
3. Friedlander PA, Bansal R, Schwartz L, et al. Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer. 2004;100:1793-1799.
4. Phillips KA, Urch M, Bishop JF. Radiation-recall dermatitis in a patient treated with paclitaxel. J Clin Oncol. 1995;13:305.